B-cell-targeted therapy for systemic lupus erythematosus-associated warm autoimmune haemolytic anaemia: a real-world comparative cohort study. (PubMed, Rheumatology (Oxford)) - Sep 26, 2026 - "Six- and 12-month ORR did not differ significantly between treatment strategies. The numerically higher complete response rate, more stable 12-month response and earlier glucocorticoid reduction with B-cell-targeted therapy, together with the telitacicept findings, are exploratory and require prospective validation."
Journal • Real-world evidence • Anemia • Autoimmune Hemolytic Anemia • Hematological Disorders • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
|
|
Chris Wincup; Heng Cao; Jin Lin; Weiqian Chen; Yiduo Sun; Yini Ke; Yuting Wang
|